182 related articles for article (PubMed ID: 25909290)
1. Expression alterations define unique molecular characteristics of spinal ependymomas.
Lourdusamy A; Rahman R; Grundy RG
Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
[TBL] [Abstract][Full Text] [Related]
2. Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?
Kim KT; Lee CH; Chung CK; Kim JH
World Neurosurg; 2018 Oct; 118():e906-e917. PubMed ID: 30031196
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
7. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures.
Lourdusamy A; Luo LZ; Storer LC; Cohen KJ; Resar L; Grundy RG
Oncotarget; 2017 Dec; 8(70):115570-115581. PubMed ID: 29383182
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the NF2 gene in oligodendrogliomas and ependymomas.
Alonso ME; Bello MJ; Arjona D; Gonzalez-Gomez P; Lomas J; de Campos JM; Kusak ME; Isla A; Rey JA
Cancer Genet Cytogenet; 2002 Apr; 134(1):1-5. PubMed ID: 11996787
[TBL] [Abstract][Full Text] [Related]
12. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.
Mack SC; Agnihotri S; Bertrand KC; Wang X; Shih DJ; Witt H; Hill N; Zayne K; Barszczyk M; Ramaswamy V; Remke M; Thompson Y; Ryzhova M; Massimi L; Grajkowska W; Lach B; Gupta N; Weiss WA; Guha A; Hawkins C; Croul S; Rutka JT; Pfister SM; Korshunov A; Pekmezci M; Tihan T; Philips JJ; Jabado N; Zadeh G; Taylor MD
Clin Cancer Res; 2015 Aug; 21(16):3750-8. PubMed ID: 25957288
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
14. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
[TBL] [Abstract][Full Text] [Related]
17. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
18. Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach.
Wang L; Zhang C; Xie Y; Jiang W; Huang J; Guo S; Xu F; Wang J
Mol Med Rep; 2019 Aug; 20(2):1531-1540. PubMed ID: 31257484
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ
Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279
[TBL] [Abstract][Full Text] [Related]
20. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]